chrisvoncsefalvay/vaers-outcomes huggingface dataset:
In 10/2021 I started to experience increase rashes on my left arm and then my right arm. Tiny raised bumps, itchy, on the outside of my arm, not the inside of my arm. I also noticed a rash below my elbow and a small cluster above  my elbow and a similar rash on cheek bones and forehead. I treated it with steroid ointments I had at my house.  L'AMARUE face cream with anti-inflammatory ingredients that helped with the rash on my face. The rash is still ongoing on my arms and it flares occasionally on my face. I have not seen a doctor for the rash, but I am planning on. On 04/13/2022, I felt a tightness and pressure in between my lungs and chest, when I swallowed or inhaled deeply and it lasted till Friday, 04/15/2022. I went to see my doctor on 04/15/2022, at that point it was getting better. The doctor theorized that maybe it was esophagus spasms or a fungal infection caused by my inhaler. I have not recovered from the rash. I have recovered from the tightness in my chest.
FELT LIKE CRAP; CHILLS; LOW GRADE FEVER; HEADACHE; This spontaneous report received from a consumer concerned a 51 year old male. The patient's weight, height, and medical history were not reported .The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A, expiry: 21/JUN/2021) dose was not reported, administered on 07-APR-2021 10:30 for prophylactic vaccination. No concomitant medications were reported. On 07-APR-2021, the subject experienced felt like crap. On 07-APR-2021, the subject experienced chills. On 07-APR-2021, the subject experienced low grade fever. On 07-APR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from felt like crap, chills, low grade fever, and headache. This report was non-serious.
Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 12-FEB-2022, at 11:50; Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 12-FEB-2022, at 11:50; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 12-FEB-2022, at 11:50) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 12-FEB-2022, at 11:50) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2022 at 11:50 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 12-Feb-2022 at 11:50 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 12-FEB-2022, at 11:50). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 12-FEB-2022, at 11:50). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 12-FEB-2022, at 11:50) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 12-FEB-2022, at 11:50) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant product reported by reporter. Vaccine went into 2 to 8 degrees Celsius in thaw state on or about 24 Dec2021. Patient received booster dose on 12-02-2022 at, 11:50:55. This vaccine was administered up until its manufacturing expiry date of 04-Apr-2022. No treatment information was provided.
1.5 degree higher than normal temperature, very bad muscle aches all over back, very bad headache, extreme fatigue for 72 hours. I used a heating pack, salonpas pads and took Advil & Tylenol for 3 days.  I still have back ache and headache at 7 days from the vaccination, but not as bad as in the beginning.
CLIENT STATED SHE NOTICED RAISED AREA TO RIGHT UPPER ARM WHICH SPREAD AND ALSO HAD ITCHING TO THE AREA. STATED IT WAS RELIEVED WITH TOPICAL CORTISONE. STATED SHE HAD NOT STARTED TYPHOID PO YET.
malaise; body aches; fever; This spontaneous case was reported by a physician and describes the occurrence of MALAISE (malaise), MYALGIA (body aches) and PYREXIA (fever) in a 29-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021B21A and 036A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MALAISE (malaise), MYALGIA (body aches) and PYREXIA (fever). At the time of the report, MALAISE (malaise), MYALGIA (body aches) and PYREXIA (fever) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  No treatment information was provided.   This case was linked to MOD-2021-411081 (Patient Link).
pt recv vax 10AM on 28APR95; by 1030AM had flat red rash approx 6cm diameter around inj site; some itching face pink; no resp sx; took PDH
chills; headache; This case was reported by a consumer via sales rep and described the occurrence of chills in a 50-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of pain (1st dose was received on unknown date, kindly refer this case - US2022AMR197023).   On 27th December 2022 13:00, the patient received the 2nd dose of Shingrix. On 27th December 2022 21:00, 8 hrs after receiving Shingrix, the patient experienced chills and headache. On 28th December 2022 11:00, the outcome of the chills and headache were recovered/resolved.   It was unknown if the reporter considered the chills and headache to be related to Shingrix.     Linked case(s) involving the same patient:  US2022AMR197023   Additional Information: GSK Receipt Date: 29-DEC-2022 Reporter's comments: Patient friend had reported to that, her husband received his second dose of Shingrix around 1 pm at the time of reporting and post injection, from around 9pm to 9am he had chills and a headache. By 11am on Wednesday 28 December, all the symptoms had resolved.  She did not know if he took any medication to help with symptoms.  Shingrix was the only vaccine he received that day.  She did not know if he had any issues with first dose but thought he mentioned he was achy then. She was not sure when he received first dose. The reporter did not consent to follow-up.; Sender's Comments:  US-GSK-US2022AMR197023:Same patient- 1st dose
Respiratory distress, Covid-19 Pneumonia.  Patient received Johnson & Johnson Covid vaccine for first dose.
The hip pain had made it difficult to impossible for him to walk; hip pain; mild to moderate annoying discomfort; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient.  A 77 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in deltoid right, administration date 04Apr2021 10:15 (Lot number: ER8729) at the age of 77 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Prostate Cancer metastatic castration sensitive", start date: 05May2019 (ongoing), notes: 1 biopsy and PEJ scan only diagnosed after B.O.B and renal obstruction.; "renal obstruction" (unspecified if ongoing); "Arthritis low back", start date: 21Jan2017 (ongoing), notes: old age sequel of 50 years age acute injury; "acute injury" (unspecified if ongoing); "MI", start date: 1995, stop date: 1996, notes: right coronary sclerotic insert, 1 stent placed; Dist changed; "right coronary sclerotic insert, 1 stent placed; Dist changed" (unspecified if ongoing); "Right inguinal lymph nodes removed", start date: 1967 (ongoing), notes: misdiagnosed infection; inappropriate surgery; erroneous post of anal apathy diagnosis. Family medical history included: his mother died at age of 80 in 1992, his father was killed by influenza virus, cirrhosis of liver at age 57, 1967, his grandparents all lived past age 80 (or 85) no direct off spring by him, sole sibling- age now 72 year; healthy, athletic, history of asthma (respective). Concomitant medication(s) included: ZYTIGA taken for neoplasm malignant, start date: 2019 (ongoing); XGEVA taken for neoplasm malignant, start date: 2019 (ongoing); PREDNISONE, start date: 2019 (ongoing); ELIGARD taken for neoplasm malignant, start date: 2019 (ongoing). The following information was reported: DISCOMFORT (non-serious) with onset Apr2021, outcome "unknown", described as "mild to moderate annoying discomfort"; ARTHRALGIA (non-serious) with onset Apr2021, outcome "recovering", described as "hip pain"; GAIT INABILITY (non-serious) with onset 11Apr2021, outcome "recovering", described as "The hip pain had made it difficult to impossible for him to walk". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of arthralgia, gait inability. The events were also described as mild to moderate annoying discomfort that had existed there since about 1-2 weeks after the 1st vaccination and that was not great enough to cause him to hammer his doctor about it. The hip pain had made it difficult to impossible for him to walk on 11Apr2021, and after his cancer treatment visit (given Xgiva routine cancer treatment injection then), eating 3.75 mg hydrocodone + 187 g acetaminophen once, prescribed relief for pain (lzya 7.5/325 mg hydrocodone apap) was referred 5 mg, afterward became able to walk without a crutch on 15Nov2021.  The reporting consumer considered the Pfizer product had a causal effect to the adverse event.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101529752 same patient/vaccine, different dose/events
received Menveo reconstituted with Pfizer Covid diluent; received Menveo reconstituted with Pfizer Covid diluent; This case was reported by a other health professional via call center representative and described the occurrence of wrong solution used in drug reconstitution in a patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVA569A, expiry date unknown) for prophylaxis.   On an unknown date, the patient received Menveo. On an unknown date, unknown after receiving Menveo, the patient experienced wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. On an unknown date, the outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were unknown.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Menveo lyophilized powder portion after being reconstituted with pfizer covid diluent when the patient was supposed to get the covid pfizer, which led to wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. No reactions reported. The reporter consented to follow up. This case was linked with 12 linked cases reported by same reporter for different patients.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR243469:Same reporter US-GLAXOSMITHKLINE-US2021AMR243475:Same reporter US-GLAXOSMITHKLINE-US2021AMR243473:Same reporter US-GLAXOSMITHKLINE-US2021AMR243472:Same reporter US-GLAXOSMITHKLINE-US2021AMR243474:Same reporter US-GLAXOSMITHKLINE-US2021AMR243470:Same reporter US-GLAXOSMITHKLINE-US2021AMR243477:Same reporter US-GLAXOSMITHKLINE-US2021AMR243478:Same reporter US-GLAXOSMITHKLINE-US2021AMR243479:Same reporter US-GLAXOSMITHKLINE-US2021AMR243480:Same reporter US-GLAXOSMITHKLINE-US2021240689:Same reporter
This spontaneous report as received from a pharmacist refers to multiple patients of unknown age and unknown gender. Information concerning concomitant medications and medical history was not provided. On an unknown date the patients were vaccinated with ZOSTAVAX (lot number, dose, and dose number were not provided), subcutaneous. The reporter stated that the majority of the patients that he had vaccinated, experienced a small red spot at the injection site, onset date not reported. The outcome of small red spot at the injection site is unknown. Additional information has been requested.
3/26 - afternoon onwards, mild arm soreness 11p fever  3/27 - 7a 100 degree fever & headache, remained at 99-100 through day 2p onwards blurry vision 7p Tylenol 11p normal temp of 97.6, no headache  3/28 - 7a no fever or headache, feeling normal except blurry vision 11a Tylenol, in hopes it would help blurry vision
got Covid had it pretty bad.; got Covid had it pretty bad.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team and product quality group. The reporter is the patient.  A 72-year-old female patient received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), in 2022 as dose 5 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; bnt162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "stage 3 kidney disease" (unspecified if ongoing), notes: She only has one kidney and stage 3 kidney disease.; "heart attack" (unspecified if ongoing); "Lung Problems" (unspecified if ongoing), notes: lung problems; "CONTRAST MEDIA ALLERGY" (unspecified if ongoing), notes: can't get a heart cat because she has an allergy to the dye. Concomitant medication(s) included: ASPIRIN [ACETYLSALICYLIC ACID]. Past drug history included: Plavix, reaction(s): "bleeding". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Mar2023, outcome "unknown" and all described as "got Covid had it pretty bad.". The patient underwent the following laboratory tests and procedures: Colonoscopy: Unknown results. Clinical course: the patient has had 5 previous Pfizer Covid vaccines and had last Pfizer Covid shot in Nov2022 or Dec2022. Then in Mar2023, got Covid and had it pretty bad.  The information on the batch/lot number for bnt162b2, bnt162b2 omi ba.4-5, bnt162b2 has been requested and will be submitted if and when received.
This spontaneous case, initially received from other non-health care professional (consumer) on 14-Nov-2018, concerning a 43-year-old, adult female patient. The patient had no medical history. The patient did not receive any concomitant medications. On 31-Oct-2018, the patient was administered AFLURIA QUADRIVALENT (dose: 0.5 ml, route of administration: intramuscular, batch number: YF40008, expiry date: 30-Jun-2019 (reported as 30Jun9) and anatomical location: not reported). On the same day, 8 hours after vaccination, the patient developed febrile seizure and convulsion. The patient's body temperature was fluctuated in between 96 Fahrenheit and fever ranges. The patient's body temperature had spiked, and the patient felt extremely hot for which she had to cool down her body with wet rags. The patient had developed chest tightness, difficulty in breathing and her heart raced as in panic attack. The patient experienced pain at the back of her neck, upper back and spinal cord which lasted for 10-12 days. The pain had lessened but still a little sore. The patient had also complained of mood swing, extreme agitation and suicidal tendencies. On 01-Nov-2018, the patient went to the clinic and consult her primary care physician (PCP) 3 times. At the time of this report, the patient was recovering from the events neck pain, spinal pain and upper back pain. The patient had not recovered from the events- febrile seizure, convulsion, chest tightness, breathing difficult, body temperature fluctuation, body temperature increased, feeling hot, heart racing, suicidal ideation, mood swings and agitation. The reporter assessed this case as serious (medically significant) and considered the causality of the neurological events as related to the suspect vaccine.
Upper central chest pain, described as squeezing/ sharp.   Pain is worse with walking.  Pain is better if she leans forward or lays all the way back.  Patient also endorses pain in neck and back.  Pulmonary embolism is considered.
Bell's Palsy- Diagnosed Treatment Steriods. Abated in 2 months. Symptoms- left sided facial paralysis resulting in left side drooling, inability to smile symmetrically and difficulty chewing
When I woke up the next day after initial vaccine, I noticed slight soreness in lungs which has not gone away.  I have now been fully vaccinated and other than this continuous soreness in my lumgs, I had the usual side effects of soreness in arm at injection site for about 3 days.  After the booster shot, in addition to the already stated, I experienced low-grade fever, slight chills, slight drowsiness the next day.
sick with chills; sick with chills; nausea; headache; aching all over; fever; inside out chills/feels like she is about to freeze/freezing; hurting all over; This is a spontaneous report from a contactable consumer (patient).   A 70-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: not reported), via an unspecified route of administration on 04MAR2021 12:30 as dose 2, single for covid-19 immunization. The patient medical history was not reported. The patient concomitant medications were not reported. It reported that the patient take Tylenol to help with the symptoms that she was experiencing after her second dose of the Pfizer BioNTech COVID-19 vaccine. Caller reported that after taking second dose yesterday around 12:30 the patient was sick with chills, nausea, headache and aching all over and about an hour ago started running a fever. The patient described that inside out chills where she did not get warm and feels like she was about to freeze. Also describes that hurting all over and that feels like her arm was going to fall off. The caller reports that the patient had no trouble after the first dose of the vaccine but they state that she had trouble with the shingles vaccine in the past where it caused her to be in bed for 3 days (details unspecified). The outcome of the events were unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Information has been received concerning a pt who was vaccinated with varicella vaccine. Subsequently the pt experienced breakthrough disease (varicella). it was noted that prescription drug treatment was not required for the outbreak. The pt recovered.
She stated that when she received the first dose, she was "sick pretty bad too".; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 54 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "She stated that when she received the first dose, she was "sick pretty bad too".".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
tooth swelled and got messed up; This is a spontaneous report from a contactable consumer reporting for herself. A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIOTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on 22Feb2021 (Batch/Lot number was not reported) as SINGLE DOSE for COVID-19 immunization. The patient medical history and concomitant medications were not reported. It was reported that, patent had first dose of the Pfizer COVID-19 vaccine on Monday (22Feb2021) and on Tuesday (23Feb2021), her tooth swelled and got messed up. She went to the dentist on (26Feb2021) and got prescribed with amoxicillin. She wanted to know if there would be an interaction with the Pfizer COVId-19 vaccine and antibiotics. Therapeutic measures were taken as a result of event: treatment included amoxicillin. Outcome for the event was reported as unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Patient's wife came in at 9:00 am on 5/18/2021 stating that her husband was complaining of arm pain that eventually led him to go to the emergency room and subsequently hospitalized the night before. She also stated that he may need surgery.
fever; body chills; bad headache; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 62-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1), for COVID-19 Immunization, reaction(s): "Body chills", "Bad headache", "Fever"; Bnt162b2 (dose 2), for COVID-19 Immunization, reaction(s): "Body chills", "Bad headache", "fever". The following information was reported: PYREXIA (non-serious), outcome "unknown", described as "fever"; CHILLS (non-serious), outcome "unknown", described as "body chills"; HEADACHE (non-serious), outcome "unknown", described as "bad headache".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201193681 same patient, different dose/event;
3/12/14 Received vaccines listed below. 3/15/14 1st seizure lasting approximately 10 min. Dx as febrile. T101. Lump noted to left thigh at injection site. CT labs to follow arrival to ER. +RSV-required nebulizers for tx. This was the first seizure that started what has been 50+ to follow. In the meantime patient has received numerous lab tests MRIs, EEGs, MD appt, medications to rule out and/or treat. Received dx of epilepsy 3/2015.
I have had extreme heartburn; nausea; and vomitting the last week; This spontaneous case was reported by a consumer and describes the occurrence of DYSPEPSIA (I have had extreme heartburn), NAUSEA (nausea) and VOMITING (and vomitting the last week) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DYSPEPSIA (I have had extreme heartburn), NAUSEA (nausea) and VOMITING (and vomitting the last week). At the time of the report, DYSPEPSIA (I have had extreme heartburn), NAUSEA (nausea) and VOMITING (and vomitting the last week) outcome was unknown.            no concomitant and treatment drugs were provided.
4/10 received inj right deltoid about 11:00am 4/10 pm right arm swollen around site, skin hard, painful. 4/11 am increased swelling radiating to elbow at inside of arm, very painful. 4/11 pm entire arm bright red, blisters noted around inj site, pain radiating to wrist. 4/12 appt at appt RX Keflex 500mg QID x 10d. 4/14 pain gone, redness diminished no new blisters denied other s/s. 4/19 all above s/s gone.